Rare diseases
Investigational molecules
Locations
Back to Germany2 clinical trials in Waldkirchen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on advanced breast cancer treatment patterns and therapeutic responses, specifically studying HER2-negative and hormone receptor-positive cases.
The research examines comprehensive spatial and temporal patterns in treatment efficacy, tracking both progression-free and overall survival rates in patients receiving first-line therapy.
Advanced studies evaluating treatment resistance patterns and therapeutic effectiveness in breast cancer patients, with particular emphasis on molecular response mechanisms.
This research aims to enhance understanding of treatment outcomes through comprehensive analysis of patient responses in advanced breast cancer cases.
Systematic evaluation of survival metrics in advanced breast cancer treatment, focusing on both short-term and long-term patient outcomes.
The research provides valuable insights into treatment effectiveness through detailed analysis of progression-free and overall survival rates.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
